Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86

Alessandro Sette1, John Sidney2, Alba Grifoni2

  • 1Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.

Cell Host & Microbe
|December 9, 2023
PubMed
Summary

This study predicts that most SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) T cell epitopes are conserved in the BA.2.86 variant. This suggests T cell responses may remain stable despite viral evolution.